Skip to main content
Watch Insiders
RTSNSector not reported

Retension Pharmaceuticals, Inc. (RTSN) Insider Trading

In the last 90 days, 2 Retension Pharmaceuticals, Inc. (RTSN) insiders reported 2 open-market purchases totaling $369,600 and no sales. The most recent open-market purchase was reported on Oct 13, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$369,600
Corporate buyers
2
Latest transaction
Oct 13, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 13, 2026Eric L. KellerCHIEF EXECUTIVE OFFICEROpen Market Purchase20,800$12.00$249,600
Oct 13, 2026Franklin M BergerCorporate insiderOpen Market Purchase10,000$12.00$120,000

Common questions

RTSN insider trading FAQ

Are RTSN insiders buying or selling?
Over the last 90 days, RTSN insiders were net buyers, reporting $369,600 of open-market purchases and $0.00 of sales.
When was the last RTSN insider purchase?
The most recent open-market purchase of Retension Pharmaceuticals, Inc. stock by an insider was reported on Oct 13, 2026, one of 2 purchases in the last 90 days.
Where does RTSN insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Retension Pharmaceuticals, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.